Pancreatic Cancer Research

ResearcherUniversity of ArizonaActive in the last 2 years

Mark A. Nelson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2312-4941; OpenAlex author ID A5102022606; NIH RePORTER profile ID 1868927. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: 1 grant · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Detection of Pancreatic Cancer Using a Methylation-Specific PCR-Based Multi-Cancer Early Detection Test Last author DOI 10.64898/2026.05.27.728292↗
  2. Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease. Last author DOI 10.1186/s13148-022-01246-2↗

Grants 1

  1. DNA methylation, Liquid Biopsy, and Pancreatic Cancer R21CA263132↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rachna T. Shroff · 1 shared paper, 1 shared grant, 2022–2023 · strength 0.75
  2. Bernard W. Futscher · 1 shared paper, 1 shared grant, 2022–2023 · strength 0.75
  3. William E. Fisher · 1 shared paper, 2026 · strength 0.26
  4. Hanh T. Pham · 1 shared paper, 2026 · strength 0.26
  5. Lukáš Vrba · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.